+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Chagas Drug"

From
From
Chagas Disease: American trypanosomiasis Market - Product Thumbnail Image

Chagas Disease: American trypanosomiasis Market

  • Report
  • January 2024
  • 25 Pages
  • United States
From
Chagas disease - Pipeline Insight, 2024 - Product Thumbnail Image

Chagas disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Chagas Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chagas Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 90 Pages
  • Global
From
  • 10 Results (Page 1 of 1)
Loading Indicator

Chagas Disease is a parasitic infection caused by the protozoan Trypanosoma cruzi. It is endemic in Latin America and affects millions of people in the region. Infectious Diseases Drugs used to treat Chagas Disease include benznidazole and nifurtimox. These drugs are used to treat both acute and chronic forms of the disease. Treatment is often long-term and requires multiple doses. The Chagas Drug market is largely concentrated in Latin America, where the disease is most prevalent. The market is expected to grow in the coming years due to increased awareness of the disease and the need for more effective treatments. The market is also expected to benefit from the development of new drugs and treatments. Companies in the Chagas Drug market include GlaxoSmithKline, Merck, Sanofi, and Novartis. These companies are involved in the development and manufacture of drugs used to treat Chagas Disease. Show Less Read more